Brain fog after cancer: can a group program sharpen the mind?

NCT ID NCT07755839

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This pilot trial tests a structured cognitive rehabilitation program called CanCOG® for cancer survivors who experience thinking difficulties—often called 'chemo brain'—after treatment for cancers outside the brain. Sixty adult survivors will be randomly assigned to either the six-week group program or their usual care. The study focuses on whether the program is feasible and acceptable, while also exploring its potential to improve perceived and objective cognitive function, mood, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CanCOG® - a structured cognitive rehabilitation program delivered in small groups over six weekly sessions, combining psychoeducation, cognitive training, and compensatory strategies.
What this could lead to
If effective, this program could offer a practical, non-drug way to help cancer survivors cope with memory, attention, and thinking difficulties, potentially improving daily life and emotional well-being.
What could go wrong
This is a small pilot study focused on feasibility, not proof of benefit. The program may not produce lasting cognitive improvements, and results may not apply to all cancer survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER-RELATED COGNITIVE DIFFICULTIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Aveiro

    Aveiro, 3810-193, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.